ketanserin has been researched along with Memory Disorders in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Memory Disorders: Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ketanserin caused an increase in AEA concentrations, 180 min after administration." | 2.87 | Peripheral endocannabinoid concentrations are not associated with verbal memory impairment during MDMA intoxication. ( de la Torre, R; Farre, M; Haijen, E; Kuypers, KPC; Olesti, E; Pastor, A; Pizarro, N; Ramaekers, JG, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haijen, E | 1 |
| Farre, M | 1 |
| de la Torre, R | 1 |
| Pastor, A | 1 |
| Olesti, E | 1 |
| Pizarro, N | 1 |
| Ramaekers, JG | 1 |
| Kuypers, KPC | 1 |
1 trial available for ketanserin and Memory Disorders
| Article | Year |
|---|---|
Peripheral endocannabinoid concentrations are not associated with verbal memory impairment during MDMA intoxication.
Topics: Adult; Arachidonic Acids; Double-Blind Method; Endocannabinoids; Female; Humans; Ketanserin; Male; M | 2018 |